𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Simple Procedure for Synthesis of Roxindole, a Dopamine D2-Receptor Agonist

✍ Scribed by Ferenc Csende

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
55 KB
Volume
334
Category
Article
ISSN
0365-6233

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cortical effects of bromocriptine, a D-2
Cortical effects of bromocriptine, a D-2 dopamine receptor agonist, in human subjects, revealed by fMRI
✍ Daniel Y. Kimberg; Geoffrey K. Aguirre; Jessica Lease; Mark D'Esposito πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 405 KB πŸ‘ 1 views

Studies of human subjects performing cognitive tasks on and off dopaminergic drugs have suggested a specific role of dopamine in cognitive processes, particularly in working memory and prefrontal "executive" functions. However, the cortical effects of these drugs have been poorly understood. We used

Repeated treatment with the selective ka
Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors
✍ Sari Izenwasser; Jane B. Acri; Paul M. Kunko; Toni Shippenberg πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 112 KB πŸ‘ 1 views

U-69593, the selective -opioid agonist, was repeatedly administered in single daily injections (0.32 mg/kg) to male, Sprague-Dawley rats. Two or ten days later, the rats were euthanized and dopamine D 1 and D 2 receptors were measured using ( 3 H]SCH 23390 or [ 3 H]sulpiride, respectively, in caudat

Characterization of 125I-IABN, a novel a
Characterization of 125I-IABN, a novel azabicyclononane benzamide selective for D2-like dopamine receptors
✍ Robert R. Luedtke; Rebekah A. Freeman; Virginia A. Boundy; Michael W. Martin; Yu πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 200 KB πŸ‘ 1 views

The properties of an (125)I-labeled structural analog of 2, 3-dimethoxy-N-[9-(4-fluorobenzyl)-9-azabicyclo[3.3. 1]nonan-3beta-yl]benzamide (MABN), (125)I-IABN, are described. (125)I-IABN was developed as a high-affinity radioligand selective for the D2-like (D2, D3, and D4) dopamine receptor subtype